Groundbreaking Access Program to Reduce Patient Barriers to Dry Eye Disease Therapy NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, ...
Anyone who has encountered an emergency healthcare situation can attest that these experiences can be incredibly costly. Of course, some incidents are unavoidable, but a significant percentage of ...
NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of Harrow Access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results